Prof Harvey specialises in the care and management of rare and uncommon rhinologic diseases. These include tumours of the nasal cavity and sinuses.
Post-operative care for tumour patients involves follow-up 1 week after surgery, then at 3 and 12 weeks. Tumour surveillance involves 3-monthly checks for 2 years, then every 6 months for 5 years. Following this, a routine check will be conducted yearly.
With malignant tumours, MRI images are usually taken every 6 months for up to 5 years. For most other tumours, clinical review, chest X-ray, blood testing, and endoscopy are carried out every 3 months.
This is an approximate follow-up schedule only. Every patient is unique, and in some cases, more or less testing is required. All tumour follow-up is conducted in accordance with the guidelines set out by the NCCN Clinical Practice Guidelines for Head and Neck Cancers.
Information about nasal and paranasal sinus cavity cancers, provided by the American Society of Clinical Oncology, can be found here. Clicking this link will take you to an external website. An excellent Australian information source is BeyondFive.org.au
We work hard to ensure that all possible treatment options will be available to you. This includes the services of the The Kinghorn Cancer Centre and we can organise specialised genetic assessments with groups such as Foundation ONE to see if tailored or indivdualised cancer interventions are an option.
The most important process is to ensure that all the information about your condition is known, so that we can make the best decision with you regarding care.
Please listen to Prof Richard Harvey present at the International Head&Neck Cancer Society Meeting in Melbourne in 2018
Please find the material below from www.cancer.org: